TEVA - Teva Pharmaceuticals
This page shows which of the focused investors we track hold TEVA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2013 it was held by 3 managers with an aggregate reported value of $43.48M, which is 0.01% of the combined portfolio.
As of Q3 2013, 3 tracked institutional managers held TEVA (Teva Pharmaceuticals) with an aggregate reported value of $43.48M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades TEVA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2013
- Ticker
- TEVA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Thomas Gayner - Markel Asset Management | 0.91% | Add +0.1% | 700,000 | $26.45M |
| 2 | David Katz - Matrix Asset Advisors | 2.30% | Add +1.2% | 450,614 | $17.02M |
| 3 | First Eagle - First Eagle Investment Management | 0.00% | - | 200 | $8K |
Loading holder history for TEVA…